Published in Lancet on April 22, 1972
Teesside coronary survey: an epidemiological study of acute attacks of myocardial infarction. Br Med J (1976) 4.86
Incidence, clinical characteristics, and short-term prognosis of angina pectoris. Br Heart J (1995) 2.24
Aspirin for unstable angina? Br Med J (Clin Res Ed) (1986) 2.08
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Saphenous vein bypass for coronary artery disease. Br Med J (1972) 1.57
Long-term oral antiarrhythmic therapy with mexiletine. Br Heart J (1978) 1.18
Predictors of risk in patients with unstable angina admitted to a district general hospital. Br Heart J (1992) 0.96
Prognosis of patients with acute myocardial infarction admitted to a coronary care unit. I: Survival in hospital. Br Heart J (1977) 0.86
Emergency myocardial revascularization. Postgrad Med J (1976) 0.85
Acute coronary insufficiency. Review of 46 patients. Br Heart J (1977) 0.83
Surgery for coronary artery disease placed in perspective. Bull N Y Acad Med (1972) 0.82
Indications for admission to a coronary care unit in patients with unstable angina. Can Med Assoc J (1980) 0.79
Current management of unstable angina. Can Med Assoc J (1978) 0.77
The Jeremiah Metzger Lecture: Evolution of management of acute coronary syndromes (unstable angina/non ST elevation myocardial infarction). Trans Am Clin Climatol Assoc (2005) 0.75
Editorial: Intermediate coronary syndrome. Br Med J (1973) 0.75
PRE-INFARCTION ANGINA: EXPERIENCE WITH 162 CONSECUTIVE PATIENTS. Cardiovasc Dis (1975) 0.75
A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell (1983) 18.86
Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies. Proc Natl Acad Sci U S A (1979) 13.60
A coronary-care unit in the routine management of acute myocardial infarction. Lancet (1967) 11.31
Guidelines for the early management of patients with myocardial infarction. British Heart Foundation Working Group. BMJ (1994) 9.91
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA (2001) 9.16
Natural history of acute coronary heart attacks. A community study. Br Heart J (1972) 8.55
Choice for periodic schedules of reinforcement. J Exp Anal Behav (1970) 5.56
Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A (1983) 5.18
A study of the clinical course and arterial blood gas tensions of patients in status asthmaticus. Q J Med (1968) 5.10
Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet (1968) 4.12
Doubts about preventing coronary heart disease. BMJ (1992) 4.04
Escherichia-Aerobacter Intermediates from Human Feces. Am J Public Health Nations Health (1937) 3.89
Problems in evaluating coronary care units. Their responsibilities and their relation to the community. Am J Cardiol (1967) 3.70
A milestone for myocardial infarction. BMJ (1988) 3.42
Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. Proc Natl Acad Sci U S A (1984) 3.32
Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet (1991) 3.29
Risk management: how doctors, hospitals and MDOs can limit the costs of malpractice litigation. Med J Aust (2000) 3.11
Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet (1987) 3.08
Ventricular fibrillation complicating acute myocardial infarction. Lancet (1968) 2.80
Dietary polyunsaturated fatty acids and composition of human aortic plaques. Lancet (1994) 2.69
Paraquat poisoning treated by forced diuresis. Br Med J (1968) 2.63
The psychological distance to reward. J Exp Anal Behav (1972) 2.59
Treatable arrhythmias in cardiac arrests seen outside hospital. Lancet (1992) 2.46
Cardiovascular responses to sustained handgrip in normal subjects and in patients with diabetes mellitus: a test of autonomic function. Clin Sci Mol Med (1974) 2.43
Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol (1989) 2.42
Segmental flexibility and complement fixation of genetically engineered chimeric human, rabbit and mouse antibodies. EMBO J (1988) 2.40
Sounding board. Risks of correcting the risks of coronary disease and stroke with drugs. N Engl J Med (1982) 2.37
Regional variations in mortality from ischaemic heart and cerebrovascular disease in Britain. Br Heart J (1978) 2.36
Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study. Lancet (1978) 2.32
Obesity and mortality in the Lipid Research Clinics Program Follow-up Study. J Clin Epidemiol (1990) 2.16
Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.14
Design and production of novel tetravalent bispecific antibodies. Nat Biotechnol (1997) 2.13
Should we not forget about mass control of coronary risk factors? Lancet (1983) 2.10
Thrombosis and oestrogens. Lancet (1967) 2.06
Treatment of ventricular arrhythmias with mexiletine (Kö 1173). Lancet (1973) 2.04
Initial metabolic and hormonal response to acute myocardial infarction. Lancet (1974) 2.02
Observations on cardiac arrythmias during laparoscopy. Br Med J (1972) 2.02
"That sort of place...where filthy men go...": a qualitative study of women's perceptions of genitourinary medicine services. Sex Transm Infect (2001) 1.99
'Might reduction of plasma cholesterol imperil cell physiology?'. J Mol Cell Cardiol (1991) 1.98
Stimulation of Bacterial Growth Rate by Methyl Germanic Oxide. J Bacteriol (1935) 1.97
Strategies for preventing and screening for coronary heart disease. Br Heart J (1985) 1.96
Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion. Lancet (1966) 1.96
A three-year trial of atromid therapy in exudative diabetic retinopathy. Diabetes (1968) 1.95
The management of hypertension--a study of records in general practice. J R Coll Gen Pract (1979) 1.95
The Edinburgh randomised trial of screening for breast cancer: description of method. Br J Cancer (1984) 1.93
Oral mexiletine in high-risk patients after myocardial infarction. Lancet (1981) 1.91
A quantitative difference in the immune response between male and female mice. Proc Soc Exp Biol Med (1968) 1.90
The binding affinity of human IgG for its high affinity Fc receptor is determined by multiple amino acids in the CH2 domain and is modulated by the hinge region. J Exp Med (1991) 1.88
Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry (1995) 1.87
Sick sinus syndrome: experience of a cardiac pacemaker clinic. Br Med J (1974) 1.86
Polypeptide products of nonsense mutations. I. Termination fragments from nonsense mutations in the Z gene of the lac operon of Escherichia coli. J Mol Biol (1970) 1.84
International child health electives for pediatric residents. Arch Pediatr Adolesc Med (1999) 1.82
Deep inspiration breath-hold technique for lung tumors: the potential value of target immobilization and reduced lung density in dose escalation. Int J Radiat Oncol Biol Phys (1999) 1.81
WHO clofibrate/cholesterol trial: clarifications. Lancet (1992) 1.79
A comparison of 5-hydroxyindoles in various regions of dog brain and cerebrospinal fluid. J Neurochem (1968) 1.79
Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials. Br Med J (1971) 1.78
Early neurological complications of coronary artery bypass surgery. Br Med J (Clin Res Ed) (1985) 1.78
A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups. Anesth Analg (1998) 1.76
Circulatory effects of heroin in patients with myocardial infarction. Lancet (1967) 1.75
Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods (1992) 1.74
Heavy chain-producing variants of a mouse myeloma cell line. J Immunol (1975) 1.73
Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J Exp Med (1993) 1.73
Ampicillin levels in sputum, serum, and saliva. Thorax (1970) 1.73
Evaluation of psychotherapy. Efficacy, effectiveness, and patient progress. Am Psychol (1996) 1.73
Lumbar strengthening in chronic low back pain patients. Physiologic and psychological benefits. Spine (Phila Pa 1976) (1993) 1.72
Artificial pacing in management of complete heart block complicating acute myocaerdial infarction. Br Med J (1968) 1.71
Pulmonary function in acute myocardial infarction. Br Med J (1965) 1.71
Primary bony and cartilaginous sarcomas of chest wall: results of therapy. Ann Thorac Surg (1992) 1.68
Ischaemic heart disease in young women. Br Med J (1974) 1.63
Present position concerning prevention of heart disease. Br Med J (1965) 1.61
Prognosis of new and worsening angina pectoris. Br Med J (1976) 1.59
Effect of intravenous propranolol on the systemic circulatory response to sustained handgrip. Am J Cardiol (1966) 1.59
Myocardial infarction in young men. Study of risk factors in nine countries. Br Heart J (1975) 1.59
Linoleic and eicosapentaenoic acids in adipose tissue and platelets and risk of coronary heart disease. Lancet (1987) 1.59
Infective endocarditis: a survey of cases in the South-East region of Scotland, 1969-72. Thorax (1976) 1.59
Predisposing factors in sudden cardiac death in Tecumseh, Michigan. A prospective study. Circulation (1970) 1.58